Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

We retrospectively analyzed non-small cell lung cancer (NSCLC) patients from a single center treated with pembrolizumab on the KEYNOTE-001 trial and evaluated the association between treatment-related adverse events (trAEs) and clinical outcomes. Investigators reported AEs on trial and graded them a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Immunol Res
Main Authors: Lisberg, Aaron, Tucker, D. Andrew, Goldman, Jonathan W, Wolf, Brian, Carroll, James, Hardy, Ariana, Morris, Karolyn, Linares, Paulina, Adame, Carlos, Spiegel, Marshall L, Wells, Courtney, McKenzie, Jordan, Ledezma, Blanca, Mendenhall, Melody, Abarca, Phillip, Bornazyan, Krikor, Hunt, Jaime, Moghadam, Nima, Chong, Natalie, Nameth, Danielle, Marx, Caitlin, Madrigal, John, Vangala, Sitaram, Shaverdian, Narek, Elashoff, David, Garon, Edward B
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6066474/
https://ncbi.nlm.nih.gov/pubmed/29382669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-17-0063
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados